Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Cycle Computing Presents at Bio-IT World Conference & Expo

    Mar 31, 2016, 12:47 PM by Michael Croft
    NEW YORK, NY - Mar 31, 2016 - –Cycle Computing, the leader in cloud computing orchestration software for Big Compute and Big Data, today announced that its CEO, Jason Stowe will deliver the introduction to one of the Keynote speeches at the Bio-IT World Conference & Expo to be held April 5-7 at the Seaport World Trade Center in Boston
    Full story
  • March News and Product Briefs

    Mar 31, 2016, 10:10 AM by Michael Croft
    Bio-IT World | The latest announcements and product launches from around the industry, including funding for new projects at 10X Genomics and Emulate, and the opening of a canine genotyping service.
    Full story
  • Quantum to Showcase Storage Solutions for Life Sciences Workflows at Bio-IT World Expo 2016

    Mar 30, 2016, 18:25 PM by Michael Croft
    SAN JOSE, CA - Mar 30, 2016 - Quantum Corp. (NYSE: QTM) today announced it will showcase multi-tier storage solutions to address challenging data management problems for genomics, bioinformatics, medical imaging and cancer researchers at the Bio-IT World Conference & Expo in Boston, April 5-7 (booth #557)
    Full story
  • Why Nestlé has been acting a lot like a drug company

    Mar 30, 2016, 14:20 PM by Michael Croft
    STAT | The Nestlé Health Science subsidiary is pouring money into companies targeting conditions like gut infections, muscle loss, and Alzheimer's disease.
    Full story
  • #BioIT16: Book Signings on Computational Biology in Drug Discovery and Cybersecurity

    Mar 30, 2016, 10:10 AM by Michael Croft
    Bio-IT World | Among the events scheduled for the 2016 Bio-IT World Conference & Expo, there will be two book signings in the exhibit hall: William Loging will speak and sign Bioinformatics and Computational Biology in Drug Discovery and Development and Mansur Hasib will speak and sign Cybersecurity Leadership: Powering the Modern Organization. Mary Chitty, Library Director & Taxonomist for Cambridge Healthtech Institute, takes a brief look at the two works.
    Full story
  • 2016 Bio-IT World Best of Show People's Choice Award Contenders

    Mar 29, 2016, 16:05 PM by Michael Croft
    Bio-IT World | Bio-IT World is pleased to announce the 2016 Best of Show competition with the Bio-IT World People’s Choice award.
    Full story
  • Danforth Center Names 2016 William H. Danforth Plant Science Fellow

    Mar 28, 2016, 12:00 PM by Michael Croft
    ST. LOUIS, MO, UNITED STATES - Mar 28, 2016 - The Donald Danforth Plant Science Center announced that Alexandra Asaro, a graduate student at Washington University in St
    Full story
  • How Veritas Genetics Plans to Make Its $999 Whole Genome Stick

    Mar 28, 2016, 12:00 PM by Michael Croft
    Bio-IT World | The myGenome service from Veritas Genetics, a $999 screen that includes a whole genome sequence and reports on an expansive number of health conditions, is running up against both the financial and regulatory limits of what genetic testing can offer today.
    Full story
  • AI Hits the Mainstream

    Mar 28, 2016, 09:22 AM by Michael Croft
    MIT Technology Review | More industries are looking for ways to use artificial intelligence. What will that mean for the technology's future?
    Full story
  • The Quest to Make Synthetic Cells Shows How Little We Know About Life

    Mar 25, 2016, 10:07 AM by Michael Croft
    The Atlantic | Scientists have created a bacterium with a minimal, life-sustaining genome, but they don't know what a third of its genes do.
    Full story
  • Paul Allen Announces Funding for Research at the Frontiers of Bioengineering and Systems Biology

    Mar 24, 2016, 11:20 AM by Michael Croft
    Bio-IT World | Paul Allen, the co-founder of Microsoft and a lavish philanthropist in the life sciences, has made a $100 million commitment to a new scientific grant program, the Paul G. Allen Frontiers Group.
    Full story
  • Google's New Stackdriver Service Can Manage Applications Across Multiple Clouds

    Mar 24, 2016, 10:35 AM by Michael Croft
    Computerworld | Google is aiming to help companies manage their applications running across public and private clouds with a new product and a set of partnerships announced at its cloud user conference.
    Full story
  • Certara’s Synchrogenix Division Provides Unique Technology Solution, Enabling Biopharma Companies to Comply with EMA Policy 70

    Mar 24, 2016, 08:29 AM by Michael Croft
    PRINCETON, NJ - Mar 24, 2016 - Certara®, the global biosimulation technology-enabled drug development company, today announced that its regulatory and medical consultancy, Synchrogenix, has introduced an artificial intelligence- (AI-) enabled solution to meet the data transparency requirements of the clinical and drug development market
    Full story
  • Runs in the Family

    Mar 23, 2016, 09:54 AM by Michael Croft
    The New Yorker | Siddartha Mukherjee, who has a family history of schizophrenia, untangles recent discoveries about the genetic and functional basis of the disease.
    Full story
  • Global Medical Research Organization, NAMSA, Decreases Time Managing Trial Master Files with Veeva Vault eTMF

    Mar 23, 2016, 08:44 AM by Michael Croft
    PLEASANTON, CA, UNITED STATES - Mar 23, 2016 - FOR IMMEDIATE RELEASENAMSA, Global Medical Research Organization, Decreases Time Managing Trial Master Files with Veeva Vault eTMF NAMSA Replaces Manual, Paper-based System to Transform Its TMF into a True Strategic AssetPLEASANTON, CA - March 22, 2016- NAMSA, a leading global medical research organization, partnered with Veeva Systems to replace its paper-based system for managing clinical trial documents
    Full story
  • Google's Greene Hastens Cloud Expansion in Race With Amazon

    Mar 22, 2016, 11:45 AM by Michael Croft
    Bloomberg | Google's new cloud chief Diane Greene had unsettling news for employees at an internal sales meeting this month in Las Vegas: They weren't taking corporate customers seriously enough and needed to sell harder, be hungrier and less complacent.
    Full story
  • No More Peanuts: Merck Pays $20M for Harvard Cancer Drug

    Mar 22, 2016, 09:35 AM by Michael Croft
    Forbes | Harvard just got $20 million in cash from Merck. Surely, some industry haters will spit out their coffee over that headline. To those in academia who see their endeavor as that of purely noble truth-seekers and educators, striking a lucrative deal with pharma is tantamount to doing business with Tony Soprano.
    Full story
  • International Team at the MDI Biological Lab Is Deciphering the Aging Code

    Mar 21, 2016, 15:45 PM by Michael Croft
    BAR HARBOR, ME - Mar 21, 2016 - BAR HARBOR, MAINE - The role of dietary restriction in extending lifespan is the subject of research being conducted at the MDI Biological Laboratory in Bar Harbor, Maine, by visiting scientist Markus Schosserer, Ph
    Full story
  • Verseon Corp – A New Twist on In Silico Drug Design

    Mar 18, 2016, 07:10 AM by Michael Croft
    Bio-IT World | For the past decade, a few companies have been pursuing the application of quantum mechanics to the modeling of ligand/receptor interactions. San-Francisco-based Verseon Corporation may have a platform in physics-based computational drug design that could change the economics and the hit quality of drug discovery.
    Full story
  • Joe Martinez to Join Center Point Clinical Services as Chief Executive Officer

    Mar 17, 2016, 10:46 AM by Michael Croft
    MINNETONKA, MN - Mar 17, 2016 - Center Point Clinical Services LLC announced today that it has appointed Joe Martinez as Chief Executive Officer
    Full story
  • «
  • 341
  • 342
  • 343
  • 344
  • 345
  • 346
  • 347 (current)
  • 348
  • 349
  • 350
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy